Lataa...
Circulating microRNAs as biomarkers for rituximab therapy, in neuromyelitis optica (NMO)
BACKGROUND: Neuromyelitis optica (NMO) is a chronic autoimmune disease of the central nervous system (CNS). The main immunological feature of the disease is the presence of autoantibodies to Aquaporin 4 (AQP4+), identified in about 82 % of cases. Currently, there are no reliable biomarkers for monit...
Tallennettuna:
| Julkaisussa: | J Neuroinflammation |
|---|---|
| Päätekijät: | , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BioMed Central
2016
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4939003/ https://ncbi.nlm.nih.gov/pubmed/27393339 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12974-016-0648-x |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|